These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
38 related items for PubMed ID: 7813599
1. Endocrine characterization of the new dopamine autoreceptor agonist roxindole. Wiedemann K, Kellner M. Exp Clin Endocrinol; 1994; 102(4):284-8. PubMed ID: 7813599 [Abstract] [Full Text] [Related]
5. Involvement of dopamine D2 and 5-HT1A receptors in roxindole-induced antinociception. Ninan I, Kulkarni SK. Indian J Exp Biol; 1999 Mar; 37(3):234-7. PubMed ID: 10641151 [Abstract] [Full Text] [Related]
6. 3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as dopamine D2 partial agonists and autoreceptor agonists. Wustrow DJ, Smith WJ, Corbin AE, Davis MD, Georgic LM, Pugsley TA, Whetzel SZ, Heffner TG, Wise LD. J Med Chem; 1997 Jan 17; 40(2):250-9. PubMed ID: 9003524 [Abstract] [Full Text] [Related]
7. Roxindole, a potential antidepressant. I. Effect on the dopamine system. Maj J, Kolodziejczyk K, Rogóz Z, Skuza G. J Neural Transm (Vienna); 1996 Jan 17; 103(5):627-41. PubMed ID: 8811507 [Abstract] [Full Text] [Related]
10. Stimulatory effects of gamma-aminohydroxybutyric acid (GABOB) on growth hormone, prolactin and cortisol release in man. Takahara J, Yunoki S, Yakushiji W, Yamauchi J, Hosogi H, Ofuji T. Horm Metab Res; 1980 Jan 17; 12(1):31-4. PubMed ID: 6244218 [Abstract] [Full Text] [Related]
11. Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression. Gründer G, Wetzel H, Hammes E, Benkert O. Psychopharmacology (Berl); 1993 Jan 17; 111(1):123-6. PubMed ID: 7870927 [Abstract] [Full Text] [Related]
12. Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers. Samuels ER, Hou RH, Langley RW, Szabadi E, Bradshaw CM. J Psychopharmacol; 2006 Nov 17; 20(6):756-70. PubMed ID: 16401653 [Abstract] [Full Text] [Related]
15. Dopaminergic neuronal systems modulate the central cardiovascular effects of TRH in rats. Jedrusiak J, Brus R, Kostrzewa RM, Słowiński Z. Pol J Pharmacol; 1995 Nov 17; 47(1):43-52. PubMed ID: 7550548 [Abstract] [Full Text] [Related]
17. Release of prolactin as well as adrenocorticotropin after administration of arginine-vasopressin to healthy men. Erfurth EM, Hedner P, Lundin S, Ekman R. Horm Metab Res; 1996 Nov 17; 28(11):599-602. PubMed ID: 8960901 [Abstract] [Full Text] [Related]